OncoMed Pharma (OMED) Reports Q4 Loss Per Share of $1.50

OncoMed Pharma (NASDAQ: OMED) reported Q4 EPS of ($1.50), versus ($0.63) reported last year. Revenue for the quarter came in at $6.84 million, versus $8.5 million reported last year.

For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49